Hydrocodone is the generic ingredient in, best tramadol prices, hydrocodone pain meds

Hydrocodone is the generic ingredient in

to establish our front-end US presence in generic sales and marketing •Entered into a long-term supply contract with Alvogen to market a range of high-potential products in the US market Awards and accolades •Awarded the 'Certificate of Merit' for 2010 by the Confederation of Indian Industry (CII) for Excellence in Environment, Health and Safety •Conferred the Greentech Gold Award presented by the Ministry of Health & Family Welfare, Government of India, and Greentech Foundation •Awarded the Good Green Governance (G3) Award by the Ministry of Water Resources & Minority Affairs, Government of India •Recognised for Outstanding Achievement in Environment Management in the Chemical sector, by Greentech Foundation •Awarded the Siemens Ecovatives-IBN Live Award 2010 in recognition of commitment to the Environment (Low Energy and Natural Resource Conservation) •Received the Bureau of Energy Efficiency (BEE) Certificate of Merit for Energy Efficiency from the Ministry of Power •Conferred the Excellent Energy Efficient Unit Award in the 9th Energy Efficiency Summit 2010, organised by CII Chapter 1 As on April 1, 2010 The business Orchid Chemicals & Pharmaceuticals Limited Cephalosporins Carbapenems NPNC (non-penicillins and non-cephalosporins) API for orals API for injectables API for injectables API for injectables API for orals Orals (hydrocodone is the generic ingredient in FDFs) Orals (FDFs) This was an important year - the first year after the transfer of our generic injectable formulations business to Hospira. We strategised and implemented our growth plan to create a sustainably profitable business model.

Supplies to Hospira: Given the favourable competitive landscape in products such as Tazobactam-Piperacillin, Meropenem and Imipenem, among others, our API supplies to Hospira contributed to robust revenues. Contractual agreements with other key players: hydrocodone is the generic ingredient in In addition to supplies to Hospira, we retained our right to supply APIs to one more generic player in each regulated market, widening our revenue potential. Deal with a Japanese major: We entered into a long-term agreement with a Japanese pharmaceutical company for supply of a Cephalosporin API, enhancing revenues.

Front-end marketing capability: We strengthened our presence in the US market by acquiring a US-based hydrocodone is the generic ingredient in marketing company Karalex Pharma LLC. - our first transnational acquisition, allowing us to provide generic products directly to US customers. Existing businesses: The conventional API business registered good growth on the back of expansion in markets and products. On the hydrocodone is the generic ingredient in dosage form front, we strengthened our marketing focus, obtained product registrations and expanded our reach. Our domestic formulations business, also registered robust growth owing to new product launches.

What we forecast for 2010-11 Revenue Earning per share Rs 20.0 US$ 350 million What we achieved in 2010-11 Revenue Earning per share Rs 22.2 US$ 400 million Numbers are on consolidated basis .V. > Chapter 2 Orchid - Strategic shifts FOLLOWING THE TRANSFER OF OUR GENERIC INJECTABLE FORMULATIONS BUSINESS, WE REVISITED OUR BUSINESS MODEL, IDENTIFIED OUR STRENGTHS AND SOUGHT TO LEVERAGE THEM AS GROWTH ACCELERATORS OVER THE MEDIUM-TERM. Strategy 1 'Supply push' to 'demand pull' Therefore, we adopted the 'demand pull' approach which took into account product requirements and supply constraints of large multi-national .



Buy phentermine cheap buy adipex online buy ultram discount buy
Combination of gaba with tramadol
Buy xanax online usa
Canada pharmacy hydrocodone